Imatinib mesylate minimally affects bcr-abl+ and normal monocyte-derived dendritic cells but strongly inhibits T cell expansion despite reciprocal dendritic cell-T cell activation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples